FDAnews
FDAnews Device Daily Bulletin

Occlutech Grabs CE Mark for Atrial Flow Regulator

Sept. 10, 2019

Occlutech’s atrial flow regulator device has been cleared on the European market for treating heart failure symptoms through decompression.

The intra-atrial shunt is placed in the patient’s septum between the left and right atriums via a minimally invasive procedure to decompress abnormal pressure.

The device improves heart function by “maintaining the correct sizing of a created shunt,”  the company said. The device comes in a variety of sizes to allow individualized treatment.

View today's stories